Philip Lee Healthcare, Pharmaceutical and Life Sciences Update Q2 2023

Key Contacts: Ronan Dunne – Partner  |   Marie Kinsella – Partner 

Welcome to the latest update from the Philip Lee Healthcare, Pharmaceutical and Life Sciences group in respect of the second quarter of 2023.

To read the full update click here.

For further information in relation to this article please contact Ronan Dunne or Marie Kinsella.

News and insights

M&A Insights H1 2023 – A cross-border deal insight guide

M&A Insights H1 2023 – A cross-border deal insight guide

Key Contacts: Eoghan Doyle - Partner  |  Andrew Tzialli - Partner We are delighted to introduce the fifth edition of the Philip Lee M&A Insights guide. In this edition, we review deal activity across H1 2023, and consider the outlook for the rest of the year...

read more
The Web3 passport

The Web3 passport

Key Contacts: Andrew Tzialli - Partner  | Head of blockchain and crypto assets, Andrew Tzialli, spoke to the Web3 passport in their latest podcast to discuss the world of blockchain and digital assets. The Web3 passport podcast explores areas such as Web3, blockchain,...

read more
Proposed changes on Compulsory Purchase Orders in Ireland

Proposed changes on Compulsory Purchase Orders in Ireland

Key Contacts: Brendan O'Connor - Senior Associate  |  Harry O'Malley - Associate The Law Reform Commission (the “LRC”) has recently published a report on the Compulsory Acquisition of Land together with a draft bill entitled “the Acquisition of Land Bill 2023”. The...

read more
Share This